Stay updated with breaking news from Lot Consistency. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Homologous boosting with the prototype Novavax COVID-19 vaccine induced robust antibody titers for Omicron BA.1, BA.2, and BA.5Study 307 (Lot Consistency) achieved its primary endpoint, showing
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
Homologous boosting with the prototype Novavax COVID-19 vaccine induced robust antibody titers for Omicron BA.1, BA.2, and BA.5 Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the consistency of the manufacturing process A durable immunogenicity response was observed following primary vaccination as well as boosting which...